Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
All content for Footprints & Impacts Podcast is the property of EHAC-ASEC and ASEQ-EHAQ and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
Navigating MCS: History, Experiences and Future Aspirations of EHAC-ASEC & ASEQ-EHAQ
Footprints & Impacts Podcast
56 minutes
1 year ago
Navigating MCS: History, Experiences and Future Aspirations of EHAC-ASEC & ASEQ-EHAQ
Send us a text In this enlightening first episode, Rohini Peris and Rosa Iacono share their personal journeys with Multiple Chemical Sensitivity (MCS) and delve into the impactful work of the Environmental Health Associations of Québec and Canada. They discuss the association's history, mission and current initiatives aimed at supporting individuals with MCS. Listeners will gain insights into the importance of education, support, collaboration in raising awareness and shaping public pol...
Footprints & Impacts Podcast
Send us a text MCS and Human Rights: Missed Opportunities and the Road Ahead Why does Multiple Chemical Sensitivity (MCS), a medical condition where over one million Canadians have a diagnosis, remain marginalized compared to other disabilities? And what will it take to finally secure recognition, rights, and justice? In this episode of Footprints & Impacts, we sit down with Me Paul-Claude Bérubé, newly appointed Executive Director of COPHAN and longtime international disability rights ...
